Literature DB >> 24043589

A new RNA-seq method to detect the transcription and non-coding RNA in prostate cancer.

Xiao-Ming Zhang1, Zhong-Wei Ma, Qiang Wang, Jian-Ning Wang, Ji-Wei Yang, Xian-Duo Li, Hao Li, Tong-Yi Men.   

Abstract

Prostate cancer is a big killer in many regions especially American men, and this year, the diagnosed rate rises rapidly. We aimed to find the biomarker or any changing in prostate cancer patients. With the development of next generation sequencing, much genomic alteration has been found. Here, basing on the RNA-seq result of human prostate cancer tissue, we tried to find the transcription or non-coding RNA expressed differentially between normal tissue and prostate cancer tissue. 10 T sample data is the RNA-seq data for prostate cancer tissue in this study, we found the differential gene is TFF3-Trefoil factor 3, which was more than seven fold change from prostate cancer tissue to normal tissue, and the most outstanding transcript is C15orf21. Additionally, 9 lncRNAs were found according our method. Finally, we found the many important non-coding RNA related to prostate cancer, some of them were long non-coding RNA (lncRNA).

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24043589     DOI: 10.1007/s12253-013-9618-0

Source DB:  PubMed          Journal:  Pathol Oncol Res        ISSN: 1219-4956            Impact factor:   3.201


  23 in total

1.  Non-coding RNAs: the architects of eukaryotic complexity.

Authors:  J S Mattick
Journal:  EMBO Rep       Date:  2001-11       Impact factor: 8.807

Review 2.  Small non-coding RNAs in animal development.

Authors:  Giovanni Stefani; Frank J Slack
Journal:  Nat Rev Mol Cell Biol       Date:  2008-03       Impact factor: 94.444

3.  Statistical inferences for isoform expression in RNA-Seq.

Authors:  Hui Jiang; Wing Hung Wong
Journal:  Bioinformatics       Date:  2009-02-25       Impact factor: 6.937

4.  Profiling the HeLa S3 transcriptome using randomly primed cDNA and massively parallel short-read sequencing.

Authors:  Ryan Morin; Matthew Bainbridge; Anthony Fejes; Martin Hirst; Martin Krzywinski; Trevor Pugh; Helen McDonald; Richard Varhol; Steven Jones; Marco Marra
Journal:  Biotechniques       Date:  2008-07       Impact factor: 1.993

5.  Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses.

Authors:  Moran N Cabili; Cole Trapnell; Loyal Goff; Magdalena Koziol; Barbara Tazon-Vega; Aviv Regev; John L Rinn
Journal:  Genes Dev       Date:  2011-09-02       Impact factor: 11.361

6.  Plasma levels of trefoil factors are increased in patients with advanced prostate cancer.

Authors:  Else Marie Vestergaard; Michael Borre; Steen Seier Poulsen; Ebba Nexø; Niels Tørring
Journal:  Clin Cancer Res       Date:  2006-02-01       Impact factor: 12.531

7.  Trefoil factor 3 is overexpressed in human prostate cancer.

Authors:  Isla P Garraway; David Seligson; Jonathan Said; Steve Horvath; Robert E Reiter
Journal:  Prostate       Date:  2004-11-01       Impact factor: 4.104

8.  The genomic complexity of primary human prostate cancer.

Authors:  Michael F Berger; Michael S Lawrence; Francesca Demichelis; Yotam Drier; Kristian Cibulskis; Andrey Y Sivachenko; Andrea Sboner; Raquel Esgueva; Dorothee Pflueger; Carrie Sougnez; Robert Onofrio; Scott L Carter; Kyung Park; Lukas Habegger; Lauren Ambrogio; Timothy Fennell; Melissa Parkin; Gordon Saksena; Douglas Voet; Alex H Ramos; Trevor J Pugh; Jane Wilkinson; Sheila Fisher; Wendy Winckler; Scott Mahan; Kristin Ardlie; Jennifer Baldwin; Jonathan W Simons; Naoki Kitabayashi; Theresa Y MacDonald; Philip W Kantoff; Lynda Chin; Stacey B Gabriel; Mark B Gerstein; Todd R Golub; Matthew Meyerson; Ashutosh Tewari; Eric S Lander; Gad Getz; Mark A Rubin; Levi A Garraway
Journal:  Nature       Date:  2011-02-10       Impact factor: 49.962

9.  Transcriptome sequencing to detect gene fusions in cancer.

Authors:  Christopher A Maher; Chandan Kumar-Sinha; Xuhong Cao; Shanker Kalyana-Sundaram; Bo Han; Xiaojun Jing; Lee Sam; Terrence Barrette; Nallasivam Palanisamy; Arul M Chinnaiyan
Journal:  Nature       Date:  2009-01-11       Impact factor: 49.962

10.  TopHat: discovering splice junctions with RNA-Seq.

Authors:  Cole Trapnell; Lior Pachter; Steven L Salzberg
Journal:  Bioinformatics       Date:  2009-03-16       Impact factor: 6.937

View more
  8 in total

1.  Transcriptome profiling of the cancer and adjacent nontumor tissues from cervical squamous cell carcinoma patients by RNA sequencing.

Authors:  Guo Peng; Wang Dan; Wu Jun; Yang Junjun; Ren Tong; Zhu Baoli; Xiang Yang
Journal:  Tumour Biol       Date:  2015-01-14

Review 2.  TERRA Gene Expression in Gastric Cancer: Role of hTERT.

Authors:  Sogand Vahidi; Ali Akbar Samadani
Journal:  J Gastrointest Cancer       Date:  2021-01-07

Review 3.  Circulating microRNAs and long non-coding RNAs in gastric cancer diagnosis: An update and review.

Authors:  Ya-Kai Huang; Jian-Chun Yu
Journal:  World J Gastroenterol       Date:  2015-09-14       Impact factor: 5.742

Review 4.  The role of lncRNAs in the development of endometrial carcinoma.

Authors:  Bi-Lan Li; Xiao-Ping Wan
Journal:  Oncol Lett       Date:  2018-07-04       Impact factor: 2.967

Review 5.  Non-coding RNAs and gastric cancer.

Authors:  Pei-Fei Li; Sheng-Can Chen; Tian Xia; Xiao-Ming Jiang; Yong-Fu Shao; Bing-Xiu Xiao; Jun-Ming Guo
Journal:  World J Gastroenterol       Date:  2014-05-14       Impact factor: 5.742

Review 6.  Long Non-Coding RNA as Potential Biomarker for Prostate Cancer: Is It Making a Difference?

Authors:  Junli Deng; Jie Tang; Guo Wang; Yuan-Shan Zhu
Journal:  Int J Environ Res Public Health       Date:  2017-03-07       Impact factor: 3.390

Review 7.  Pathological bases and clinical impact of long noncoding RNAs in prostate cancer: a new budding star.

Authors:  Tao Xu; Chang-Ming Lin; Shu-Qi Cheng; Jie Min; Li Li; Xiao-Ming Meng; Cheng Huang; Lei Zhang; Zi-Yu Deng; Jun Li
Journal:  Mol Cancer       Date:  2018-07-23       Impact factor: 27.401

Review 8.  Emerging Roles of Circular RNAs in Osteosarcoma.

Authors:  Chenyu Wang; Ming Ren; Xin Zhao; Ao Wang; Jincheng Wang
Journal:  Med Sci Monit       Date:  2018-10-04
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.